Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma

Investor logo

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Science. Official publication website can be found on muni.cz.
Authors

BOŘÁNKOVÁ Karolína KRCHNIAKOVÁ Mária LECK Lionel Y W KUBIŠTOVÁ Adéla NERADIL Jakub JANSSON Patric J HOGARTY Michael D ŠKODA Jan

Year of publication 2023
Type Article in Periodical
Magazine / Source Cell Death and Disease
MU Faculty or unit

Faculty of Science

Citation
Web https://www.nature.com/articles/s41419-023-06278-x
Doi http://dx.doi.org/10.1038/s41419-023-06278-x
Keywords ABDOMINAL AORTIC-ANEURYSMS; N-MYC; MITOCHONDRIAL TRANSLATION; DRUG-RESISTANCE; PROTEIN; DOXYCYCLINE; PHOSPHORYLATION; DEGRADATION; ACTIVATION; EXPRESSION
Attached files
Description Mitochondria are central for cancer responses to therapy-induced stress signals. Refractory tumors often show attenuated sensitivity to apoptotic signaling, yet clinically relevant molecular actors to target mitochondria-mediated resistance remain elusive. Here, we show that MYC-driven neuroblastoma cells rely on intact mitochondrial ribosome (mitoribosome) processivity and undergo cell death following pharmacological inhibition of mitochondrial translation, regardless of their multidrug/mitochondrial resistance and stem-like phenotypes. Mechanistically, inhibiting mitoribosomes induced the mitochondrial stress-activated integrated stress response (ISR), leading to downregulation of c-MYC/N-MYC proteins prior to neuroblastoma cell death, which could be both rescued by the ISR inhibitor ISRIB. The ISR blocks global protein synthesis and shifted the c-MYC/N-MYC turnover toward proteasomal degradation. Comparing models of various neuroectodermal tumors and normal fibroblasts revealed overexpression of MYC proteins phosphorylated at the degradation-promoting site T58 as a factor that predetermines vulnerability of MYC-driven neuroblastoma to mitoribosome inhibition. Reducing N-MYC levels in a neuroblastoma model with tunable MYCN expression mitigated cell death induction upon inhibition of mitochondrial translation and functionally validated the propensity of neuroblastoma cells for MYC-dependent cell death in response to the mitochondrial ISR. Notably, neuroblastoma cells failed to develop significant resistance to the mitoribosomal inhibitor doxycycline over a long-term repeated (pulsed) selection. Collectively, we identify mitochondrial translation machinery as a novel synthetic lethality target for multidrug-resistant MYC-driven tumors.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.